SV Life Sciences Raises $273.5M For Planned $400M Fund
SV Life Sciences LLP, a private and venture capital investment firm that targets companies focused on biotechnology, medical devices and health care services, has raised $273.5 million toward a planned $400...To view the full article, register now.
Already a subscriber? Click here to view full article